CN111505275B - Cas9 nucleic acid isothermal amplification-based immunochromatography multiple gene detection method - Google Patents
Cas9 nucleic acid isothermal amplification-based immunochromatography multiple gene detection method Download PDFInfo
- Publication number
- CN111505275B CN111505275B CN202010200985.8A CN202010200985A CN111505275B CN 111505275 B CN111505275 B CN 111505275B CN 202010200985 A CN202010200985 A CN 202010200985A CN 111505275 B CN111505275 B CN 111505275B
- Authority
- CN
- China
- Prior art keywords
- detection
- detected
- pad
- nucleic acid
- membrane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention relates to the technical field of biotechnology and medical inspection, in particular to an immunochromatography multiple gene detection method based on Cas9 nucleic acid isothermal amplification, which comprises the following steps: (1) extracting genomic DNA to be detected from a sample to be detected; (2) Taking the genomic DNA to be detected as a template, and carrying out multiple isothermal amplification to obtain multiple amplified nucleic acid products; (3) And (3) dripping the multiple amplified nucleic acid products on immunochromatographic test paper, wherein the immunochromatographic test paper is provided with a plurality of detection lines and a quality control line, observing the colors of the detection lines and the quality control line, and determining the detection result. The detection method can simultaneously detect a plurality of nucleic acid products, has simple and convenient operation, short detection time and instant and readable result, can be widely applied to basic level detection and family detection, and is not limited by instruments.
Description
Technical Field
The invention relates to the technical field of biotechnology and medical inspection, in particular to an immunochromatography multiple gene detection method based on Cas9 nucleic acid isothermal amplification.
Background
Nucleic acid detection has found widespread use in a variety of fields, including criminal investigation, detection of pathogenic microorganisms, disease diagnosis, and the like. Generally, the content of the target nucleic acid in the environmental sample or the physiological sample is very small, and in order to make the result more accurate, the target nucleic acid fragment is often required to be amplified. Among them, polymerase Chain Reaction (PCR) is the most widely used nucleic acid amplification technique. However, this technique relies on thermal cycling, requires expensive specialized equipment, and is not suitable for testing in ordinary homes or remote locations.
With the clinical and field detection requirements of biotechnology, isothermal amplification of nucleic acids has been developed to replace PCR technology. Common isothermal amplification techniques for nucleic acids include nucleic acid sequence dependent amplification (NASBA), strand Displacement Amplification (SDA), loop-mediated isothermal amplification (LAMP), recombinase Polymerase Amplification (RPA), and the like.
Chinese patent literature discloses a constant-temperature nucleic acid detection and analysis method and a kit based on Cas9 nickase coupled DNA polymerase, and the application publication number is CN 110607355A, which is called Cas9nAR method for short. According to the invention, through the Cas9 nickase with DNA nicking activity, the DNA polymerase with strand displacement activity and the carefully-selected primers, the specific amplification of genomes in biological samples such as microorganisms and cells under the normal temperature condition is realized, the detection sensitivity reaches 1 copy number DNA of a 10 microliter reaction system, the specificity of single base discrimination is realized, and the method has great potential in the precise and rapid detection application of disease-related genes (single nucleotide polymorphism), pathogens in blood, bacterial viruses and the like. However, this method uses fluorescence as an output signal, requires expensive instrument assistance, has high detection cost, can amplify only one nucleic acid fragment at a time, and has limitations in the field of gene multiplex detection.
Disclosure of Invention
In order to overcome the problems of high cost, single detection object and low universality of the traditional nucleic acid detection method, the invention provides the immunochromatography multiple gene detection method based on the isothermal amplification of the Cas9 nucleic acid, which has the advantages of low cost, no special requirements on instruments, capability of simultaneously detecting various nucleic acid products, rapidness, high efficiency and visualized detection results, and can be widely applied to basic layer detection and family detection.
In order to achieve the purpose, the invention adopts the following technical scheme:
an immunochromatography multiple gene detection method based on isothermal amplification of Cas9 nucleic acid comprises the following steps:
(1) Extracting genomic DNA (target DNA) to be detected from a sample to be detected;
(2) Taking the genome DNA to be detected as a template, and performing multiple isothermal amplification under the action of Cas9 nickase, sgRNA, a labeled primer and DNA polymerase to obtain multiple amplified nucleic acid products;
(3) And (3) dropwise adding the multiple amplified nucleic acid products on immunochromatographic test paper, wherein the immunochromatographic test paper is provided with a plurality of detection lines and a quality control line, observing the colors of the detection lines and the quality control line, and determining a detection result.
The immunochromatography technology is a rapid diagnosis technology, and the technology uses color-developing particles such as colloidal gold and the like as tracers to be applied to antigen-antibody reaction, and is most commonly used as an immune colloidal gold chromatography test strip which consists of a water absorption pad, a combination pad, a nitrocellulose membrane and a sample pad. The sample containing the substance to be detected is moved up along the membrane by the capillary action of the nitrocellulose membrane, and the receptor immobilized on the membrane binds thereto to cause a specific reaction. The antigen-antibody complex is accumulated continuously, and the chromogenic particles mark the precipitate for color development, thereby achieving the purpose of detection. The amount of the marker is in direct proportion to the amount of the antigen in the sample, and the quantitative detection of the substance to be detected is realized by detecting the amount of the marker. The antigen (antibody) labeling technology is combined with the immunochromatography technology, the detection result can be obtained within 15min, and the purpose of rapid detection is realized. Nucleic acid molecules can be detected by immunochromatographic test strips by labeling small molecule antigens.
The invention provides a method for amplifying nucleic acid in multiple ways, which is suitable for immunochromatography test paper, on the basis of a Cas9nAR method. The method realizes the simultaneous amplification of various sequences under the combined action of Cas9 nickase, a specially designed sgRNA, a primer and DNA polymerase, and uses an immunochromatography test strip to read a detection result so as to realize the multiple detection of genes. The method can detect various nucleic acid products simultaneously, has simple and convenient operation, short detection time (5-10 minutes) and instant and readable result, can be widely applied to basic level detection and family detection, and is not limited by instruments.
Preferably, in step (2), the multiple isothermal amplification process comprises the following steps:
(a) Using the genome DNA to be detected as a template, and respectively reacting the genomic DNA to be detected with the sgRNA by using the Cas9 nickase in a water bath at the temperature of 20-42 ℃ for 20-30 min to obtain a mixed solution; the water bath temperature is more preferably 37 ℃ and the water bath reaction time is more preferably 20min.
(b) Adding DNA polymerase, a labeled primer, NEBuffer 2 and dNTP into the mixed solution, uniformly mixing, and reacting for 1-1.5 h in a water bath at 20-42 ℃ to obtain the multiple amplified nucleic acid product. The bath temperature is more preferably 37 ℃ and the bath reaction time is more preferably 1h.
Preferably, in step (2), the labeled primers comprise a first primer and a second primer, and the first primer is labeled with a biotin group; the second primer is labeled with a small molecule compound with a specific antibody, such as a digoxin group, a FITC group, or other compound group.
Preferably, in the step (3), the detection line is coated with a specific antibody corresponding to the small molecule compound marked by the second primer; the quality control line is coated with a biotin-modified goat anti-mouse IgG antibody.
The detection principle of the invention is as follows: the invention designs a multiple immunochromatographic test strip based on the principle of antigen-antibody specific binding. The invention respectively designs a pair of specific primers aiming at target DNAs of different samples to be detected, wherein the first primer is labeled with biotin groups, and the second primer is labeled with different specific groups (such as digoxin groups, FITC groups or other compound groups) respectively for distinguishing. Specific products corresponding to the target are amplified through Cas9nAR, and different products simultaneously carry biotin groups (from the first primer) and specific groups (from the second primer). Dropwise adding the amplification product solution onto a test strip, enabling the solution of the product to be detected to migrate on the chromatographic strip through capillary action, combining biotin groups carried by the product with streptavidin-modified latex microsphere particles coated on a latex microsphere pad in the migration process to form a compound, specifically combining the compound with antibodies corresponding to specific groups coated on different detection lines when the compound migrates to a detection area again, enabling the specific product to be enriched on a chromatographic material of the detection area of the chromatographic strip, and obtaining a macroscopic reaction compound through the color of the latex microsphere particles, so that visual color development is formed. The product which is not enriched continuously flows forwards and finally migrates to the quality control area, and forms visual color development by immunological combination with the goat anti-mouse IgG antibody modified by the biotin on the product.
Preferably, in the step (3), the immunochromatographic test strip comprises a base plate, and a sample pad, a latex microsphere pad, an NC membrane and a water absorption pad which are sequentially overlapped and bonded on the base plate; the adjacent parts of the sample pad, the latex microsphere pad, the NC membrane and the water absorption pad are partially overlapped; the NC membrane is coated with a plurality of mutually parallel detection lines and a quality control line, the detection lines are close to one side of the latex microsphere pad, and the quality control line is far away from the latex microsphere pad and is close to one side of the water absorption pad; for detection, the multiple amplified nucleic acid products are dropped onto the sample pad, and the sample pad portion is immersed in a flow buffer (4X sodium citrate buffer containing 2% by volume BSA and 0.05% Tween20, pH 7.0).
Specifically, the immunochromatographic test paper is a strip. The front end of the sample pad is stuck on the front end of the bottom plate, the tail end of the sample pad is lapped on the latex microsphere pad, the latex microsphere pad is positioned between the sample pad and the NC membrane, the front end of the latex microsphere pad is lapped and stuck on the bottom plate, and the rear end of the latex microsphere pad extends out of the upper part of the front end of the NC membrane by a certain length; the NC film comprises a detection area and a quality control area, is arranged in the middle of the bottom plate, and is partially overlapped with the latex microsphere pad. The front end of the NC membrane is inserted between the latex microsphere cushion and the bottom plate and is adhered on the bottom plate; the water absorption pad is lapped on the NC membrane and is adhered to the rear end of the bottom plate; the detection lines and the quality control line are respectively coated on the NC film correspondingly to form parallel bands which are respectively immune coatings capable of being combined with the label of the detection object.
Specifically, during detection, the multiple amplified nucleic acid products are dripped on a sample pad, the immunochromatographic test paper is placed in a flowing buffer solution in a mode that the sample pad faces downwards, and the multiple amplified nucleic acid products flow from the sample pad to the latex microsphere pad, are specifically combined with the latex microsphere on the latex microsphere pad, flow through a detection line and a quality control line on an NC (numerical control) membrane and finally flow to a water absorption pad. As the complex continues to flow through the NC membrane, it will specifically bind to the corresponding antibody on it to form a sandwich complex.
Preferably, the sample pad is a glass cellulose membrane or a polyester cellulose membrane; the NC membrane is a nitrocellulose membrane.
Preferably, the latex microsphere pad comprises a membrane body and a streptavidin-labeled latex microsphere particle coating uniformly coated on the surface of the membrane body; the membrane body is a glass cellulose membrane or a polyester cellulose membrane.
Preferably, in step (3), the detection result includes:
when the quality control line and the detection lines are simultaneously colored or the quality control line and any detection line are colored, judging that the sample to be detected contains a corresponding object to be detected; and when only the quality control line is developed, judging that the sample to be detected does not contain the object to be detected. If the quality control line and the detection line are not colored, the detection fails, and the test paper needs to be replaced for re-detection.
Preferably, in step (1), the sample to be detected contains at least two specific gene sequences.
Preferably, in step (1), the sample to be detected is derived from one or more of animal cells, plant cells, microorganisms and viruses.
Therefore, the invention has the following beneficial effects: the method is based on a Cas9nAR multiple isothermal amplification technology to carry out rapid and specific amplification on a sample to be detected containing multiple substances to be detected, and an immunochromatography test paper is used for obtaining a visual detection result; the object to be detected can be semi-quantitatively detected by judging the color depth of the detection line, and the using place is not limited. The method can detect various nucleic acid products simultaneously, has simple and convenient operation, short detection time (5-10 min), and instant and readable result, can be widely applied to basic level detection and family detection, and is not limited by instruments.
Drawings
FIG. 1 is a schematic diagram showing the principle of detection of Escherichia coli and Salmonella by immunochromatography in example 1.
FIG. 2 is a graph showing the feasibility results of the immunochromatographic multiplex gene E.coli and Salmonella target DNA detection in example 1.
FIG. 3 is a graph showing the results of specificity of the immunochromatographic multiplex gene E.coli and Salmonella target DNA detection in example 1.
FIG. 4 is a graph showing the results of the sensitivity of the immunochromatographic multiplex gene E.coli and Salmonella target DNA detection in example 1.
FIG. 5 is a graph showing the results of specificity of the detection of target DNA of Escherichia coli and Salmonella mixed in milk in example 3.
FIG. 6 is a graph showing the sensitivity results of the detection of target DNA of Escherichia coli and Salmonella mixed in milk in example 3.
Detailed Description
The technical solution of the present invention is further specifically described below by using specific embodiments and with reference to the accompanying drawings.
In the present invention, all the equipment and materials are commercially available or commonly used in the art, and the methods in the following examples are conventional in the art unless otherwise specified.
Example 1 detection of Escherichia coli and Salmonella by multiple immunochromatographic diagnostic test strips
In this example, the DNA amplification template is derived from a genome or plasmid extracted from the kit, the primers are synthesized by biotechnology companies, the sgRNA is obtained by in vitro transcription, and 20 bases at the 5' end of the sgRNA are a seed sequence complementary to the pre-spacer.
The detection is carried out according to the detection principle of the immunochromatography multiple gene escherichia coli and salmonella shown in figure 1:
(1) Extracting the genomic DNA to be detected from the sample to be detected: carrying out shake culture on Escherichia coli ATCC35128 and salmonella ASL1174 in LB liquid culture medium until exponential growth phase (OD = 0.4-0.6), taking 1 ml of bacterial liquid to extract bacterial DNA (target DNA),
(2) Performing multiple isothermal amplification by using a target DNA as a template:
(a) Reacting Cas9 nickase and two pairs of sgRNAs aiming at escherichia coli and salmonella target genes in a water bath at 37 ℃ for 20 minutes to form a Cas9n/sgRNA compound; the amplification template sequence is an uidA target gene sequence in an Escherichia coli genome (SEQ, ID, NO. 1); the amplification template sequence is an invA target gene sequence (SEQ, ID, NO. 2) in a salmonella genome;
(b) Mixing the two pairs of the total four Cas9n/sgRNA compounds obtained in the step (a), DNA polymerase, a labeled primer, NEBuffer 2 and dNTP in a water bath at 37 ℃ to react for 1h to obtain a double-amplification nucleic acid product of characteristic genes of escherichia coli and salmonella; as shown in table 1, sgrnas for localization of escherichia coli uidA gene include sgrnas 1-1 (SEQ, ID, no. 3) and sgrnas 1-2 (SEQ, ID, no. 4), and sgrnas for localization of salmonella invA gene include sgrnas 2-1 (SEQ, ID, no. 5) and sgrnas 2-2 (SEQ, ID, no. 6), in which underlined sequences are complementary to the pre-region sequences of the target; as shown in Table 3, the primers for amplification of the uidA gene of Escherichia coli include digoxin-labeled primer 1-1 (SEQ, ID, NO. 13) and biotin-labeled primer 1-2 (SEQ, ID, NO. 14), and the primers for amplification of the invA gene of Salmonella include FTIC-labeled primer 2-1 (SEQ, ID, NO. 15) and biotin-labeled primer 2-2 (SEQ, ID, NO. 16); (3) Dropping the multiple amplified nucleic acid products on the sample pad of the strip-shaped immunochromatographic test strip, putting the immunochromatographic test strip in a flow buffer (4 × sodium citrate buffer containing 2% by volume BSA and 0.05% Tweeen 20, pH 7.0) with the sample pad facing downward, allowing the multiple amplified nucleic acid products to flow from the sample pad to the latex microsphere pad, specifically binding to the latex microspheres thereon, then flowing through the detection line and the quality control line on the NC membrane, and finally flowing onto the water absorption pad, observing the colors of the detection line and the quality control line, and determining the detection result.
The immunochromatographic test paper comprises a bottom plate, and a sample pad, a latex microsphere pad, an NC membrane and a water absorption pad which are sequentially overlapped and bonded on the bottom plate; the adjacent parts of the sample pad, the latex microsphere pad, the NC membrane and the water absorption pad are partially overlapped; the NC membrane is coated with two mutually parallel detection lines and a quality control line, the detection lines are close to one side of the latex microsphere pad, and the quality control line is far away from the latex microsphere pad and is close to one side of the water absorption pad; the front end of the sample pad is adhered to the front end of the bottom plate, the tail end of the sample pad is lapped on the latex microsphere pad, and the latex microsphere pad comprises a membrane body and a streptavidin-labeled latex microsphere particle coating which is uniformly coated on the surface of the membrane body; the latex microsphere pad is positioned between the sample pad and the NC membrane, the front end of the latex microsphere pad is lapped and stuck on the bottom plate, and the rear end of the latex microsphere pad extends out of the upper part of the front end of the NC membrane by a certain length; the front end of the NC membrane is inserted between the latex microsphere cushion and the bottom plate and is adhered on the bottom plate; the water absorption pad is lapped on the NC membrane and is adhered to the rear end of the bottom plate; the two detection lines and one quality control line are respectively coated on the NC film correspondingly to form parallel bands which are respectively immune coatings capable of being combined with the label of a detection object: the detection line 1 is coated with digoxin antibody, the detection line 2 is coated with FITC antibody, and the quality control line is coated with biotin-modified goat anti-mouse IgG antibody. The sample pad adopts a glass cellulose membrane, the latex microsphere pad adopts a glass cellulose membrane, and the NC membrane adopts a nitrocellulose membrane.
Table 1 sgrna sequences
Wherein, the synthesis of sgRNA is carried out in three steps: as shown in table 2, in the first step, a T7 promoter sequence was inserted into a sgRNA plasmid template with primers T7-F-sgRNA (SEQ, ID, no. 7) and R (SEQ, ID, no. 8) to obtain a template with a promoter; secondly, synthesizing a sgRNA template by using the template, wherein a common primer R and a characteristic primer F-sgRNA1-1 (SEQ, ID, NO. 9), 1-2 (SEQ, ID, NO. 10), 2-1 (SEQ, ID, NO. 11) and 2-2 (SEQ, ID, NO. 12) are needed in the synthesis process; and thirdly, transcribing the sgRNA template in vitro by using a transcription kit.
TABLE 2 primers for sgRNA in vitro transcription
TABLE 3 primer sequences
As shown in fig. 2, when detecting target DNA of escherichia coli and salmonella, only in the presence of DNA polymerase, two pairs of Cas9n/sgRNA complexes, and two pairs of primers, both detection lines can be colored, and the absence of any one primer or Cas9n/sgRNA complex can not color the corresponding detection line, and the absence of DNA polymerase can not perform amplification reaction, and both detection lines can not be colored.
As shown in FIG. 3, if the amplified product contains DNA of Escherichia coli and Salmonella, the two detection lines and the quality control line will be colored; if only contains Escherichia coli, only the detection line 1 and the quality control line are developed; if the salmonella is contained, only the detection line 2 and the quality control line are developed; if the two bacteria are not contained, neither detection line is developed, and only the quality control line is developed; if the quality control line and the detection line are not colored, the detection fails, and the test paper needs to be replaced for re-detection.
The sensitivity of this method was evaluated as shown in FIG. 4, with a detection limit of 100 copies/microliter.
Example 2
The difference between the example 2 and the example 1 is that the immunochromatographic test strip is different, the sample pad and the latex microsphere pad are made of a polyester cellulose membrane, the temperature of the water bath in the multiple isothermal amplification process is 42 ℃, and the rest processes are completely the same. The detection result of this embodiment is equivalent to that of embodiment 1, and will not be described herein.
Example 3
Escherichia coli and salmonella were mixed with milk, and after overnight storage at room temperature, the mixture was used as a sample for experimental detection in the same manner as in example 1. As shown in fig. 5, the method still has good specificity for the bacteria in the food sample. As shown in fig. 6, the method has a limit of 100 colonies/ml for detection of bacteria in the food sample.
The above description is only a preferred embodiment of the present invention, and is not intended to limit the present invention in any way, and other variations and modifications may be made without departing from the spirit of the invention as set forth in the claims.
Sequence listing
<110> Zhejiang industrial university
<120> immunochromatography multiple gene detection method based on isothermal amplification of Cas9 nucleic acid
<160> 16
<170> SIPOSequenceListing 1.0
<210> 1
<211> 566
<212> DNA
<213> Escherichia coli (2 Ambystoma laterale x Ambystoma jeffersonia)
<400> 1
agcatcaggg cggctataca ccgtttgaag ccgatgtcac gccgtatgtt attgccggga 60
aaagtgtgcg tatcaccgtt tgtgtgaaca acgaactgaa ctggcagact atcccgccgg 120
gaatggtgat taccgacgaa aacggcaaga aaaagcagtc ttacttccat gatttcttta 180
attatgccgg gatccatcgc agcgtaatgc tctacaccac gccgaacacc tgggtggacg 240
atatcaccgt ggtgacgcat gtcgcgcaag actgtaacca cgcgtctgtt gactggcagg 300
tggtggccaa tggtgatgtc agcgttgaac tgcgtgatgc ggatcaacag gtggttgcaa 360
ctggacaagg cactagcggg actttgcaag tggtgaatcc acacctctgg caaccgggtg 420
aaggttatct ctatgaactg tgcgtcacag ccaaaagcca gacagagtgt gatatctacc 480
cgcttcgcgt cggcatccgg tcagtggcag tgaagggcga acagttcctg attaaccaca 540
aaccgttcta ctttactggc tttggt 566
<210> 2
<211> 2176
<212> DNA
<213> Salmonella (2 Ambystoma laterale x Ambystoma jeffersonia)
<400> 2
gatattgcct acaagcatga aatggcagaa cagcgtcgta ctattgaaaa gctgtcttaa 60
tttaatatta acaggatacc tatagtgctg ctttctctac ttaacagtgc tcgtttacga 120
cctgaattac tgattctggt actaatggtg atgatcattt ctatgttcgt cattccatta 180
cctacctatc tggttgattt cctgatcgca ctgaatatcg tactggcgat attggtgttt 240
atggggtcgt tctacattga cagaatcctc agtttttcaa cgtttcctgc ggtactgtta 300
attaccacgc tctttcgtct ggcattatcg atcagtacca gtcgtcttat cttgattgaa 360
gccgatgccg gtgaaattat cgccacgttc gggcaattcg ttattggcga tagcctggcg 420
gtgggttttg ttgtcttctc tattgtcacc gtggtccagt ttatcgttat taccaaaggt 480
tcagaacgtg tcgcggaagt cgcggcccga ttttctctgg atggtatgcc cggtaaacag 540
atgagtattg atgccgattt gaaggccggt attattgatg cggatgccgc gcgcgaacgg 600
cgaagcgtac tggaaaggga aagccagctt tacggttcct ttgacggtgc gatgaagttt 660
atcaaaggtg acgctattgc cggcatcatt attatctttg tgaactttat tggcggtatt 720
tcggtgggga tgactcgcca tggtatggat ttgtcctccg ccctgtctac ttataccatg 780
ctgaccattg gtgatggtct tgtcgcccag atccccgcat tgttgattgc gattagtgcc 840
ggttttatcg tgacccgcgt aaatggcgat acggataata tggggcggaa tatcatgacg 900
cagctgttga acaacccatt tgtattggtt gttacggcta ttttgaccat ttcaatggga 960
actctgccgg gattcccact gccggttttt gttattttat cggtggtttt aagcgtactc 1020
ttctatttta aattccgtga agcaaaacgt agcgccgcca aacctaaaac cagcaaaggc 1080
gagcagccgc tcagtattga ggaaaaagaa gggtcgtcgt taggactgat tggcgatctc 1140
gataaagtct ctacagagac cgtaccgttg atattacttg tgccgaagag ccggcgtgaa 1200
gatctggaaa aagctcaact tgcggagcgt ctacgtagtc agttctttat tgattatggc 1260
gtgcgcctgc cggaagtatt gttacgagat ggcgagggcc tggacgataa cagcatcgta 1320
ttgttgatta atgagatccg tgttgaacaa tttacggtct attttgattt gatgcgagtg 1380
gtaaattatt ccgatgaagt cgtgtccttt ggtattaatc caacaatcca tcagcaaggt 1440
agcagtcagt atttctgggt aacgcatgaa gagggggaga aactccggga gcttggctat 1500
gtgttgcgga acgcgcttga tgagctttac cactgtctgg cggtgaccgt ggcgcgcaac 1560
gtcaatgaat atttcggtat tcaggaaaca aaacatatgc tggaccaact ggaagcgaaa 1620
tttcctgatt tacttaaaga agtgctcaga catgccacgg tacaacgtat atctgaagtt 1680
ttgcagcgtt tgttaagcga acgtgtttcc gtgcgtaata tgaagttaat tatggaagcg 1740
ctcgcattgt gggcgccaag agaaaaagat gtcattaacc ttgtggagca tattcgtgga 1800
gcaatggcgc gttatatttg tcataaattc gccaatggcg gcgaattacg agcagtaatg 1860
gtatctgctg aagttgagga tgttattcgc aaagggatcc gtcagacctc tggcagtacc 1920
ttcctcagcc ttgacccgga agcctccgct aatttgatgg atctcattac acttaagttg 1980
gatgatttat tgattgcaca taaagatctt gtcctcctta cgtctgtcga tgtccgtcga 2040
tttattaaga aaatgattga aggtcgtttt ccggatctgg aggttttatc tttcggtgag 2100
atagcagata gcaagtcagt gaatgttata aaaacaatat aagggcttaa ttaaggaaaa 2160
gatctatgca acattt 2176
<210> 6
<211> 80
<212> RNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
aauaacauac ggcgugacau uuuuagagcu agaaauagca aguuaaaaua aggcuagucc 60
guuaucaacu ugaaaaagug 80
<210> 4
<211> 80
<212> RNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
ucauagagau aaccuucacc uuuuagagcu agaaauagca aguuaaaaua aggcuagucc 60
guuaucaacu ugaaaaagug 80
<210> 5
<211> 80
<212> RNA
<213> Artificial Sequence (Artificial Sequence)
<400> 5
aucugguuga uuuccugauc uuuuagagcu agaaauagca aguuaaaaua aggcuagucc 60
guuaucaacu ugaaaaagug 80
<210> 6
<211> 80
<212> RNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
ucgauuuauu aagaaaauga uuuuagagcu agaaauagca aguuaaaaua aggcuagucc 60
guuaucaacu ugaaaaagug 80
<210> 8
<211> 30
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 8
gatcccgcga aattaatacg actcactata 30
<210> 8
<211> 35
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 8
ataaaaaacg cccggcggca accgagcgtt ctgaa 35
<210> 9
<211> 58
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 9
taatacgact cactatagaa taacatacgg cgtgacatgt tttagagcta gaaatagc 58
<210> 10
<211> 58
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 10
taatacgact cactatagtc atagagataa ccttcaccgt tttagagcta gaaatagc 58
<210> 11
<211> 58
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 11
taatacgact cactatagat ctggttgatt tcctgatcgt tttagagcta gaaatagc 58
<210> 12
<211> 58
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 12
taatacgact cactatagtc gatttattaa gaaaatgagt tttagagcta gaaatagc 58
<210> 13
<211> 51
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 13
gactagttat cccatgtcac gccgtatgtt attgccggga aaagdgdtgt g 51
<210> 14
<211> 53
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 14
gactagttat cccggtgaag gttatctcta tgaacccggt bdttgccaga ggt 53
<210> 15
<211> 50
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 15
gactagttat cccatctggt tgatttcctg atcgcactcd ttgaatatcg 50
<210> 16
<211> 53
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 16
gactagttat ccctcgattt attaagaaaa tgacgacgga cabdttcgac aga 53
Claims (7)
1. The application of the non-diagnostic objective immunochromatography multiple gene detection method based on isothermal amplification of Cas9 nucleic acid in detection of Escherichia coli and salmonella is characterized by comprising the following steps:
(1) Extracting genomic DNA to be detected from a sample to be detected; the sample to be detected comprises two specific gene sequences;
(2) Taking the genome DNA to be detected as a template, and performing multiple isothermal amplification under the action of Cas9 nickase, sgRNA, a labeled primer and DNA polymerase to obtain multiple amplified nucleic acid products; the multiple isothermal amplification process comprises the following steps:
(a) Taking the genome DNA to be detected as a template, and reacting the genome DNA to be detected with a Cas9 nickase and sgRNA of the genome DNA to be detected in a water bath at 20 to 42 ℃ for 20 to 30min to obtain a mixed solution;
(b) Adding DNA polymerase, a labeled primer, NEBuffer 2 and dNTP into the mixed solution, uniformly mixing, and reacting for 1 to 1.5h in a water bath at 20 to 42 ℃ to obtain a multiple amplified nucleic acid product; the labeled primers comprise a first primer and a second primer, the first primer being labeled with a biotin group; the second primer is labeled with a small molecule compound with a specific antibody; the marked primer comprises a sequence shown as SEQ, ID, NO.13 and SEQ, ID, NO.14, and a sequence shown as SEQ, ID, NO.15 and SEQ, ID, NO. 16; respectively labeling different small molecular compounds on second primers aiming at escherichia coli and salmonella;
(3) And (3) dropwise adding the multiple amplified nucleic acid products on immunochromatographic test paper, wherein the immunochromatographic test paper is provided with 2 detection lines and one quality control line, observing the colors of the detection lines and the quality control line, and determining a detection result.
2. The use of claim 1, wherein in step (3), the detection line is coated with a specific antibody corresponding to the small molecule compound labeled with the second primer; the quality control line is coated with a biotin-modified goat anti-mouse IgG antibody.
3. The use of claim 1, wherein in step (3), the immunochromatographic test strip comprises a base plate, and a sample pad, a latex microsphere pad, an NC membrane and a water absorbent pad which are sequentially overlapped and bonded on the base plate; the adjacent parts of the sample pad, the latex microsphere pad, the NC membrane and the water absorption pad are partially overlapped; 2 parallel detection lines and a quality control line are coated on the NC membrane, the detection lines are close to one side of the latex microsphere pad, and the quality control line is far away from the latex microsphere pad and close to one side of the water absorption pad; for detection, the multiple amplified nucleic acid products are dropped onto the sample pad, and the sample pad is partially immersed in the running buffer.
4. Use according to claim 3, wherein the sample pad is a glass cellulose or polyester cellulose membrane; the NC membrane is a nitrocellulose membrane.
5. The use of claim 3, wherein the latex microsphere mat comprises a membrane body and a streptavidin-labeled latex microsphere particle coating uniformly coated on the surface of the membrane body; the membrane body is a glass cellulose membrane or a polyester cellulose membrane.
6. The use according to claim 1, wherein in step (3), the detection result comprises:
when the quality control line and the detection line are simultaneously colored or the quality control line and any detection line are colored, judging that the sample to be detected contains a corresponding object to be detected; and when only the quality control line is developed, judging that the sample to be detected does not contain the object to be detected.
7. The use according to any one of claims 1 to 6, wherein in step (1), the sample to be detected is derived from one or more of animal cells, plant cells, microorganisms and viruses.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010200985.8A CN111505275B (en) | 2020-03-20 | 2020-03-20 | Cas9 nucleic acid isothermal amplification-based immunochromatography multiple gene detection method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010200985.8A CN111505275B (en) | 2020-03-20 | 2020-03-20 | Cas9 nucleic acid isothermal amplification-based immunochromatography multiple gene detection method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111505275A CN111505275A (en) | 2020-08-07 |
| CN111505275B true CN111505275B (en) | 2023-03-31 |
Family
ID=71871577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010200985.8A Active CN111505275B (en) | 2020-03-20 | 2020-03-20 | Cas9 nucleic acid isothermal amplification-based immunochromatography multiple gene detection method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111505275B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111961705A (en) * | 2020-08-11 | 2020-11-20 | 佛山科学技术学院 | Detection method of salmonella |
| CN112881672A (en) * | 2021-01-11 | 2021-06-01 | 南京钟鼎生物技术有限公司 | Universal type colloidal gold test strip for detecting polynucleic acid products and preparation method and application thereof |
| CN112680550B (en) * | 2021-01-27 | 2023-11-03 | 重庆威斯腾前沿生物研究院有限责任公司 | Immunochromatography method for detecting SARS-CoV-2N gene by non-diagnostic dcas9 mediation |
| CN112779358B (en) * | 2021-01-27 | 2023-06-09 | 重庆威斯腾前沿生物研究院有限责任公司 | Immunochromatography method for detecting HPV16 type E6 gene by non-diagnostic dcas9 mediation |
| CN112779346B (en) * | 2021-01-27 | 2023-11-03 | 重庆威斯腾前沿生物研究院有限责任公司 | Immunochromatography method for detecting tubercle bacillus through dcas9 mediation for non-diagnostic purpose |
| CN113584134B (en) * | 2021-09-06 | 2024-01-30 | 青岛金斯达生物技术有限公司 | Isothermal nucleic acid detection system based on CRISPR-Cas9, and method and application thereof |
| CN116875440A (en) * | 2023-06-21 | 2023-10-13 | 无锡百泰克生物技术有限公司 | Multiple nucleic acid detector, test paper and method based on chromatography |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108060209A (en) * | 2017-12-26 | 2018-05-22 | 中科智测(天津)科技有限公司 | A kind of kit and detection method of recombinase constant-temperature amplification combination immunity colloidal gold test paper strip detection salmonella |
| CN108486258A (en) * | 2018-01-29 | 2018-09-04 | 南昌大学 | A kind of kit and its method of visual quickly detection food-borne pathogens |
| CN109913562A (en) * | 2019-03-12 | 2019-06-21 | 西安医学院 | Based on PCR-gold magnetic nano immune chromatography mycoplasma pneumoniae detection method |
| CN109943663A (en) * | 2019-03-22 | 2019-06-28 | 安徽深蓝医疗科技股份有限公司 | For recombinase amplification detection method, test strips and its application of 18 genotype of HPV 16 and HPV |
| CN110079583A (en) * | 2019-05-27 | 2019-08-02 | 重庆博艾迈迪森生物科技有限公司 | A kind of immunochromatography detection method, detection kit and its application of nucleic acid |
| WO2019233385A1 (en) * | 2018-06-03 | 2019-12-12 | 上海吐露港生物科技有限公司 | Use of high-temperature-resistant cas protein, and method and reagent kit for detecting target nucleic acid molecule |
| CN110607355A (en) * | 2019-02-18 | 2019-12-24 | 华东理工大学 | Cas9 nickase-coupled DNA polymerase-based constant-temperature nucleic acid detection and analysis method and kit |
-
2020
- 2020-03-20 CN CN202010200985.8A patent/CN111505275B/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108060209A (en) * | 2017-12-26 | 2018-05-22 | 中科智测(天津)科技有限公司 | A kind of kit and detection method of recombinase constant-temperature amplification combination immunity colloidal gold test paper strip detection salmonella |
| CN108486258A (en) * | 2018-01-29 | 2018-09-04 | 南昌大学 | A kind of kit and its method of visual quickly detection food-borne pathogens |
| WO2019233385A1 (en) * | 2018-06-03 | 2019-12-12 | 上海吐露港生物科技有限公司 | Use of high-temperature-resistant cas protein, and method and reagent kit for detecting target nucleic acid molecule |
| CN110607355A (en) * | 2019-02-18 | 2019-12-24 | 华东理工大学 | Cas9 nickase-coupled DNA polymerase-based constant-temperature nucleic acid detection and analysis method and kit |
| CN109913562A (en) * | 2019-03-12 | 2019-06-21 | 西安医学院 | Based on PCR-gold magnetic nano immune chromatography mycoplasma pneumoniae detection method |
| CN109943663A (en) * | 2019-03-22 | 2019-06-28 | 安徽深蓝医疗科技股份有限公司 | For recombinase amplification detection method, test strips and its application of 18 genotype of HPV 16 and HPV |
| CN110079583A (en) * | 2019-05-27 | 2019-08-02 | 重庆博艾迈迪森生物科技有限公司 | A kind of immunochromatography detection method, detection kit and its application of nucleic acid |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111505275A (en) | 2020-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111505275B (en) | Cas9 nucleic acid isothermal amplification-based immunochromatography multiple gene detection method | |
| US6090592A (en) | Method for performing amplification of nucleic acid on supports | |
| EP0784701B1 (en) | Method and apparatus for performing amplification of nucleic acid on supports | |
| EP0837946B1 (en) | Detection of amplified nucleic acid sequences using bifunctional haptenization and dyed microparticles | |
| CN102373273B (en) | Kit for detecting nucleic acid of mycobacterium tuberculosis | |
| US6682648B1 (en) | Electrochemical reporter system for detecting analytical immunoassay and molecular biology procedures | |
| AU2002360934B2 (en) | Method in the form of a dry rapid test for detecting nucleic acids | |
| JPH09503910A (en) | Oligonucleotides and methods for the detection of Trachoma chlamydia | |
| EP0892856B1 (en) | A method for the amplification and detection of a nucleic acid fragment of interest | |
| TW201002825A (en) | Novel method and kit for diagnosis of mycobacterium tuberculosis and nontuberculous mycobacterium | |
| WO1997032044A9 (en) | A method for the amplification and detection of a nucleic acid fragment of interest | |
| WO1999007879A1 (en) | Electrochemical reporter system for detecting analytical immunoassay and molecular biology procedures | |
| US6468751B1 (en) | Method and apparatus for performing amplification of nucleic acid on supports | |
| CN111073984A (en) | Kit and method for detecting target nucleic acid | |
| CN114517236A (en) | PCR primer, kit and detection method for detecting klebsiella pneumoniae | |
| CN112680550B (en) | Immunochromatography method for detecting SARS-CoV-2N gene by non-diagnostic dcas9 mediation | |
| JP2009296948A (en) | Primer for pcr, method for detecting target nucleic acid and method for detecting target biomolecule | |
| CN110551623A (en) | Paper microfluid chip, device and kit for nucleic acid detection and application thereof | |
| CN112779346B (en) | Immunochromatography method for detecting tubercle bacillus through dcas9 mediation for non-diagnostic purpose | |
| US5871906A (en) | Method for detection of amplified nucleic acid products and related diagnostic assays | |
| WO2022053665A1 (en) | Tools & methods useful for detection of lactose intolerance and uses thereof | |
| PT677589E (en) | METHODS TEST ELEMENT AND TEST CASE FOR SEMI-QUANTITATIVE NUCLEIC ACID DETECTION | |
| KR102625074B1 (en) | Microparticle-based detecting kit for nucleic acid and Method for detecting nucleic acid amplification product | |
| CN112410447B (en) | Amplification primer group of pseudomonas aeruginosa and detection method | |
| CN216738348U (en) | Nucleic acid multi-joint detection device suitable for isothermal amplification technology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |